Search
Menu
Home
HTB
2024
October
October 2024
Contents
Special reports
HIV diagnoses in England jump by 51% in 2023: missing targets and highlighting disparities in access to care
Major update of UK PrEP guidelines online for public consultation
Conference reports
HIVR4P 2024: Introduction
Urgency of planning broad vaccine-like access to lenacapavir PrEP globally
Impact on CD4 counts of once-monthly islatravir in PrEP studies: early macaque results with MK-8527 follow-on compound
Lenacapavir PrEP in cisgender gay men, trans and gender-diverse people: results of the PURPOSE 2 study
HIVR4P 2024: Context of PrEP in Latin America
Treatment access
Helsinki Declaration: 2024 edition upholds ethical access to treatment
Gilead announces plans to support generic lenacapavir for low-income countries
mpox
Confirmed mpox clade 1b case in Germany: risk remains low for EU/EEA
Lack of tecovirimat activity against mpox clade 1
Efficacy of MVA-BN vaccine: systematic review
Mpox outbreak in Australia: half of cases had previously received a vaccine
WHO situation report on mpox
Coinfections and complications
Kidney transplants from HIV positive donors to HIV recipients
Treatment advocacy
US NIAID updates HIV guide to person-centred language
On the web
Long COVID essentials: link to online resources
HTB RSS
Early access
Vaccination effectively limits mpox progression: lower efficacy in people living with HIV
27 May 2025
US update guidelines for statin use in people living with HIV
26 May 2025
HIV activists in the US call for action and Zachie Achmet brings South African perspective
26 May 2025
Scientific, legal and ethical crisis from halting ongoing NIH studies: TAG statement
22 May 2025
All early access reports
Current issues
May 2025
April 2025
March 2025
Back issues
Special report
Scientific, legal and ethical crisis from halting ongoing NIH studies: TAG statement
22 May 2025
More from HTB
Conference reports
Conference shortcuts
Articles by subject
PDFs
Subscribe
HTB homepage
Home
i-Base homepage
Donate